Multisystem Inflammatory Disorder

The CDC and Council of State and Territorial Epidemiologists published a revised case definition of multisystem inflammatory syndrome in children, a potentially serious complication of SARS-CoV-2 infection.

The risk for multisystem inflammatory syndrome in children, or MIS-C, is reduced to just one in a million when a person receives at least one dose of COVID-19 vaccine, researchers reported in The Lancet Child & Adolescent Health.

NEW YORK — Surges of multisystem inflammatory syndrome in children, or MIS-C, are “almost predictable,” according to an expert’s presentation.

According to a recent study, physicians with higher scores on the American Board of Internal Medicine exam were less likely to prescribe opioids for back pain than physicians with lower exam scores.

Hospitals in the U.S. and the CDC have reported rising incidence of multisystem inflammatory syndrome in children after COVID-19 infection.